Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... using α/β T cell -depleted PSCT in with alternative donor sources with hematologic malignancies receiving alternative donor (unrelated or partially matched related) mobilized peripheral stem cells ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  2. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... have become cancer. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving ... years who have a 7-8/8 HLA -A,B,C,DRB1 allele matched unrelated volunteer marrow and/or peripheral blood stem cell (PBSC) donor match ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  3. Kathryn (Kate) Bauer, Retired MDS Patient Living Life to the Fullest Since Transplant

    ... I received a stem cell bone marrow transplant from an unrelated donor from the international registry!  I was in isolation at the Hospital ...

    Patient Chronicle last updated 07/23/2015 - 9:38am.

  4. The Nurse’s Role in Preparing Patients for Stem Cell Transplantation

    ... this phase is especially critical if the patient has an unrelated donor . The completion of work-up and the initiation of conditioning must ...

    Page last updated 10/16/2013 - 3:02pm.

  5. Pasireotide in Prevention of GI Toxicity

    ... Consenting 4-6/6 antigen matched stem cell donor or genetically matched unrelated bone marrow or adult stem cell donor. 18 years of age or ...

    Clinical Trial last updated 06/06/2016 - 10:41am.

  6. New York Blood Center National Cord Blood Program

    ... candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  7. Transplants With Unlicensed Preserved Cord Blood

    ... outline safety and effectiveness requirements for cells from unrelated donors or when HCT/Ps are more than minimally manipulated, assure ... and distribution protocol conducted by the National Marrow Donor Program (NMDP) for unlicensed cryopreserved cord blood units (CBUs) in ...

    Clinical Trial last updated 04/27/2016 - 3:20pm.

  8. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... is also designed to block your body's ability to reject the donor's bone marrow cells. Melphalan and busulfan are designed to bind to ... failure. The source can be autologous, related or unrelated. Exclusion Criteria:  ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  9. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... a transplant utilizing mis-matched related or matched unrelated donors following a preparative regimen of busulfan, fludarabine ... human leukocyte antigen ( HLA ) compatible unrelated or HLA-genotypically matched related donors (no fully matched sibling donor). Patients and donors may be of either gender or any ethnic ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  10. Intra-Osseous Co-Transplant of UCB and hMSC

    ... This clinical trial studies intra-osseous donor umbilical cord blood and mesenchymal stromal cell co-transplant in ... (defined as matched in HLA A, B, C, and DRB1) related or unrelated donors Cord Blood Units available through NMDP with the ...

    Clinical Trial last updated 05/02/2016 - 11:15am.